605177 东亚药业
已收盘 10-12 15:00:00
资讯
新帖
简况
异动快报:东亚药业(605177)10月12日10点24分触及跌停板
证券之星 · 10-12 10:25
异动快报:东亚药业(605177)10月12日10点24分触及跌停板
股市必读:东亚药业新发布《东亚药业关于可转债转股结果暨股份变动公告》
证券之星 · 10-12 01:14
股市必读:东亚药业新发布《东亚药业关于可转债转股结果暨股份变动公告》
异动快报:东亚药业(605177)10月9日13点30分触及涨停板
证券之星 · 10-09
异动快报:东亚药业(605177)10月9日13点30分触及涨停板
东亚药业(605177)10月8日主力资金净买入3379.81万元
证券之星 · 10-08
东亚药业(605177)10月8日主力资金净买入3379.81万元
异动快报:东亚药业(605177)10月8日10点3分触及涨停板
证券之星 · 10-08
异动快报:东亚药业(605177)10月8日10点3分触及涨停板
东亚药业(605177)9月24日主力资金净买入1333.01万元
证券之星 · 09-24
东亚药业(605177)9月24日主力资金净买入1333.01万元
东亚药业(605177)9月10日股东户数1.17万户,较上期增加17.1%
证券之星 · 09-21
东亚药业(605177)9月10日股东户数1.17万户,较上期增加17.1%
东亚药业:截至2026年9月10日,公司股东人数为11696户
证券之星 · 09-21
东亚药业:截至2026年9月10日,公司股东人数为11696户
每周股票复盘:东亚药业(605177)制剂业务取得突破进展
证券之星 · 09-20
每周股票复盘:东亚药业(605177)制剂业务取得突破进展
股市必读:东亚药业新发布《东亚药业关于股票交易异常波动的公告》
证券之星 · 09-14
股市必读:东亚药业新发布《东亚药业关于股票交易异常波动的公告》
东亚药业(605177)披露股票交易异常波动公告,9月10日股价上涨8.47%
证券之星 · 09-10
东亚药业(605177)披露股票交易异常波动公告,9月10日股价上涨8.47%
股市必读:东亚药业(605177)登9月8日交易所龙虎榜
证券之星 · 09-09
股市必读:东亚药业(605177)登9月8日交易所龙虎榜
异动快报:东亚药业(605177)9月8日10点26分触及涨停板
证券之星 · 09-08
异动快报:东亚药业(605177)9月8日10点26分触及涨停板
9月7日东亚药业(605177)龙虎榜数据
证券之星 · 09-07
9月7日东亚药业(605177)龙虎榜数据
每周股票复盘:东亚药业(605177)股东户数减少13.24%,净利亏损1.18亿
证券之星 · 09-06
每周股票复盘:东亚药业(605177)股东户数减少13.24%,净利亏损1.18亿
东亚药业(605177)8月31日股东户数1万户,较上期减少13.24%
证券之星 · 09-03
东亚药业(605177)8月31日股东户数1万户,较上期减少13.24%
东亚药业:截至2026年8月31日,公司股东人数为9988户
证券之星 · 09-03
东亚药业:截至2026年8月31日,公司股东人数为9988户
股市必读:东亚药业新发布《东亚药业关于2026年半年度计提资产减值准备的公告》
证券之星 · 09-01
股市必读:东亚药业新发布《东亚药业关于2026年半年度计提资产减值准备的公告》
东亚药业(605177)披露2026年半年度报告,8月31日股价上涨1.03%
证券之星 · 08-31
东亚药业(605177)披露2026年半年度报告,8月31日股价上涨1.03%
图解东亚药业中报:第二季度单季净利润同比下降256.84%
证券之星 · 08-30
图解东亚药业中报:第二季度单季净利润同比下降256.84%
加载更多
公司概况
公司名称:
浙江东亚药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-11-25
主营业务:
浙江东亚药业股份有限公司的主营业务是化学原料药、医药中间体、化学制剂的研发、生产和销售业务。公司的主要产品是抗细菌类药物(β-内酰胺类和喹诺酮类)、消化系统药物、皮肤用抗真菌药物等。公司在浙江三门、浙江临海、江西九江建有一体化的制药基地,并在上海张江药谷、杭州下沙医药港小镇设有现代化的研发中心,先后获得“国家高新技术企业”“浙江省专利示范企业”“台州市管理创新十强企业”等称号。
发行价格:
31.13
{"stockData":{"symbol":"605177","market":"SH","secType":"STK","nameCN":"东亚药业","latestPrice":25.46,"timestamp":1791788400000,"preClose":28.29,"halted":0,"volume":11794045,"delay":0,"changeRate":-0.1,"floatShares":113999999,"shares":114999999,"eps":-1.4868,"marketStatus":"已收盘","change":-2.83,"latestTime":"10-12 15:00:00","open":28.29,"high":28.29,"low":25.46,"amount":306000000,"amplitude":0.1,"askPrice":25.46,"askSize":3220,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.4868,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791855000000},"marketStatusCode":5,"adr":0,"adjPreClose":28.29,"symbolType":"stock","openAndCloseTimeList":[[1791768600000,1791775800000],[1791781200000,1791788400000]],"highLimit":31.12,"lowLimit":25.46,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":114706012,"isCdr":false,"pbRate":1.84,"roa":"--","roe":"--","epsLYR":-0.72,"committee":0,"marketValue":2920000000,"turnoverRate":0.1038,"status":1,"floatMarketCap":2894000000},"requestUrl":"/m/hq/s/605177","defaultTab":"news","newsList":[{"id":"2674828814","title":"异动快报:东亚药业(605177)10月12日10点24分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2674828814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674828814?lang=zh_cn&edition=full","pubTime":"2026-10-12 10:25","pubTimestamp":1791771945,"startTime":"0","endTime":"0","summary":"证券之星10月12日盘中消息,10点24分东亚药业(605177)触及跌停板。其所属行业化学制药目前下跌。领涨股为莱美药业。该股为阿尔茨海默病,化学原料药,医药概念热股。10月9日的资金流向数据方面,主力资金净流入2429.52万元,占总成交额6.03%,游资资金净流入1426.04万元,占总成交额3.54%,散户资金净流出3855.56万元,占总成交额9.57%。近5日资金流向一览见下表:东亚药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200006972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674843435","title":"股市必读:东亚药业新发布《东亚药业关于可转债转股结果暨股份变动公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674843435","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674843435?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:14","pubTimestamp":1791738850,"startTime":"0","endTime":"0","summary":"公司公告汇总东亚药业关于可转债转股结果暨股份变动公告浙江东亚药业股份有限公司发布关于可转债转股结果暨股份变动的公告。截至2026年9月30日,累计已有23,789,000元“东亚转债”转为公司A股普通股,累计转股1,154,512股,占转股前总股本的1.0163%。本季度内,共3,000元可转债转股,转股数量为147股。公司总股本因转股及股权激励股份回购注销略有变动,相关证券变更登记已于2026年8月26日完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674439833","title":"异动快报:东亚药业(605177)10月9日13点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2674439833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674439833?lang=zh_cn&edition=full","pubTime":"2026-10-09 13:36","pubTimestamp":1791524179,"startTime":"0","endTime":"0","summary":"证券之星10月9日盘中消息,13点30分东亚药业(605177)触及涨停板。其所属行业化学制药目前上涨。领涨股为向日葵。该股为阿尔茨海默病,化学原料药,医药概念热股,当日阿尔茨海默病概念上涨0.77%,化学原料药概念上涨0.75%,医药概念上涨0.06%。10月8日的资金流向数据方面,主力资金净流入3379.81万元,占总成交额9.73%,游资资金净流出1364.2万元,占总成交额3.93%,散户资金净流出2015.61万元,占总成交额5.8%。近5日资金流向一览见下表:东亚药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900017878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673029714","title":"东亚药业(605177)10月8日主力资金净买入3379.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673029714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673029714?lang=zh_cn&edition=full","pubTime":"2026-10-08 15:22","pubTimestamp":1791444133,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月8日收盘,东亚药业报收于25.72元,上涨6.02%,换手率11.68%,成交量13.28万手,成交额3.47亿元。10月8日的资金流向数据方面,主力资金净流入3379.81万元,占总成交额9.73%,游资资金净流出1364.2万元,占总成交额3.93%,散户资金净流出2015.61万元,占总成交额5.8%。东亚药业主营业务:化学原料药、医药中间体的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800013996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673984044","title":"异动快报:东亚药业(605177)10月8日10点3分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2673984044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673984044?lang=zh_cn&edition=full","pubTime":"2026-10-08 10:05","pubTimestamp":1791425129,"startTime":"0","endTime":"0","summary":"证券之星10月8日盘中消息,10点3分东亚药业(605177)触及涨停板。其所属行业化学制药目前下跌。领涨股为华北制药。该股为化学原料药,医药,阿尔茨海默病概念热股,当日化学原料药概念上涨0.36%。9月30日的资金流向数据方面,主力资金净流出112.41万元,占总成交额0.82%,游资资金净流出1372.72万元,占总成交额9.97%,散户资金净流入1485.13万元,占总成交额10.79%。近5日资金流向一览见下表:东亚药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800005937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669574094","title":"东亚药业(605177)9月24日主力资金净买入1333.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669574094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669574094?lang=zh_cn&edition=full","pubTime":"2026-09-24 15:22","pubTimestamp":1790234558,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月24日收盘,东亚药业报收于25.86元,上涨3.9%,换手率6.15%,成交量6.99万手,成交额1.79亿元。9月24日的资金流向数据方面,主力资金净流入1333.01万元,占总成交额7.43%,游资资金净流出207.7万元,占总成交额1.16%,散户资金净流出1125.31万元,占总成交额6.28%。东亚药业主营业务:化学原料药、医药中间体的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400021450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669502154","title":"东亚药业(605177)9月10日股东户数1.17万户,较上期增加17.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669502154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669502154?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:38","pubTimestamp":1789983500,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东亚药业披露,截至2026年9月10日公司股东户数为1.17万户,较8月31日增加1708.0户,增幅为17.1%。在化学制药行业个股中,东亚药业股东户数低于行业平均水平,截至9月10日,化学制药行业平均股东户数为3.64万户。从股价来看,2026年8月31日至2026年9月10日,东亚药业区间涨幅为14.03%,在此期间股东户数增加1708.0户,增幅为17.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100022544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669558011","title":"东亚药业:截至2026年9月10日,公司股东人数为11696户","url":"https://stock-news.laohu8.com/highlight/detail?id=2669558011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669558011?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:37","pubTimestamp":1789976238,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业(605177)09月21日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,请告知公司9月10日的股东人数是多少,谢谢!东亚药业回复:尊敬的投资者,您好!截至2026年9月10日,公司股东人数为11696户。感谢您对公司的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100014304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668906108","title":"每周股票复盘:东亚药业(605177)制剂业务取得突破进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2668906108","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668906108?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:14","pubTimestamp":1789838051,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘,东亚药业报收于24.69元,较上周的23.57元上涨4.75%。本周,东亚药业9月17日盘中最高价报26.58元,股价触及近一年最高点。2026年上半年,公司研发费用4,286.10万元,占营业收入的9.19%。截至报告期末,公司累计获得授权专利45项,其中发明专利37项;制剂业务已有15个品规、涉及11个制剂品种的上市许可申请获得国家药监局受理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667680604","title":"股市必读:东亚药业新发布《东亚药业关于股票交易异常波动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667680604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667680604?lang=zh_cn&edition=full","pubTime":"2026-09-14 01:53","pubTimestamp":1789321989,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,东亚药业报收于23.57元,下跌4.61%,换手率11.59%,成交量13.17万手,成交额3.07亿元。公司公告汇总:东亚药业股票于9月8日至10日连续三个交易日收盘价涨幅偏离值累计达20%,触发异常波动;公司披露2026年半年度净利润为-118,376,942.74元,自2024年度以来连续亏损。经公司自查并书面问询控股股东及实际控制人,截至公告披露日,不存在应披露而未披露的重大事项。公司提醒投资者注意二级市场交易风险及业绩亏损带来的投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591889","title":"东亚药业(605177)披露股票交易异常波动公告,9月10日股价上涨8.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591889","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591889?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:08","pubTimestamp":1789049299,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,东亚药业报收于24.71元,较前一交易日上涨8.47%,最新总市值为28.34亿元。近日,东亚药业发布《关于股票交易异常波动的公告》。公告显示,公司股票于2026年9月8日、9月9日、9月10日连续三个交易日内日收盘价格涨幅偏离值累计达20%,属于股票交易异常波动情形。经公司自查并书面问询控股股东及实际控制人,截至公告披露日,不存在应披露而未披露的重大事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000041870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374935","title":"股市必读:东亚药业(605177)登9月8日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666374935?lang=zh_cn&edition=full","pubTime":"2026-09-09 00:47","pubTimestamp":1788886031,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘,东亚药业报收于22.06元,上涨10.02%,涨停,换手率9.69%,成交量11.02万手,成交额2.3亿元。交易信息汇总:东亚药业因日收盘价格涨幅偏离值达7%,登上沪深交易所9月8日龙虎榜,系近5个交易日内第2次上榜。公司公告汇总:东亚药业将于2026年9月15日10:30–11:30通过价值在线平台召开2026年半年度业绩说明会,董事长兼总经理池骋、独立董事冯燕、财务负责人王小敏、董事会秘书周剑波将出席。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900001987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665034139","title":"异动快报:东亚药业(605177)9月8日10点26分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665034139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665034139?lang=zh_cn&edition=full","pubTime":"2026-09-08 10:31","pubTimestamp":1788834693,"startTime":"0","endTime":"0","summary":"证券之星9月8日盘中消息,10点26分东亚药业(605177)触及涨停板。其所属行业化学制药目前上涨。领涨股为纳微科技。该股为化学原料药,阿尔茨海默病,医药概念热股,当日化学原料药概念上涨0.23%,阿尔茨海默病概念上涨0.21%,医药概念上涨0.06%。9月7日的资金流向数据方面,主力资金净流出138.13万元,占总成交额0.39%,游资资金净流入479.1万元,占总成交额1.35%,散户资金净流出340.97万元,占总成交额0.96%。近5日资金流向一览见下表:东亚药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800011281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665199314","title":"9月7日东亚药业(605177)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2665199314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665199314?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:54","pubTimestamp":1788774861,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年9月7日公布的交易公开信息显示,东亚药业因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月7日收盘,东亚药业报收于20.05元,下跌8.74%,换手率15.14%,成交量17.21万手,成交额3.54亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365577","title":"每周股票复盘:东亚药业(605177)股东户数减少13.24%,净利亏损1.18亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365577","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365577?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:38","pubTimestamp":1788629892,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,东亚药业报收于21.97元,较上周的21.45元上涨2.42%。本周,东亚药业9月4日盘中最高价报25.1元,股价触及近一年最高点。东亚药业当前最新总市值25.2亿元,在化学制药板块市值排名138/149,在两市A股市值排名4742/5214。本周关注点股本股东变化:股东户数较8月20日减少13.24%。户均持股数量由上期的9965.0股上升至1.15万股,户均持股市值为24.89万元。本次计提减少公司合并报表利润总额6,771.31万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878034","title":"东亚药业(605177)8月31日股东户数1万户,较上期减少13.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878034","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664878034?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:29","pubTimestamp":1788427781,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东亚药业披露,截至2026年8月31日公司股东户数为9988.0户,较8月20日减少1524.0户,减幅为13.24%。在化学制药行业个股中,东亚药业股东户数低于行业平均水平,截至8月31日,化学制药行业平均股东户数为3.66万户。从股价来看,2026年8月20日至2026年8月31日,东亚药业区间涨幅为4.33%,在此期间股东户数减少1524.0户,减幅为13.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300031458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664623822","title":"东亚药业:截至2026年8月31日,公司股东人数为9988户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664623822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664623822?lang=zh_cn&edition=full","pubTime":"2026-09-03 15:33","pubTimestamp":1788420788,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业(605177)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年8月31日,公司股东人数多少?东亚药业回复:尊敬的投资者,您好!截至2026年8月31日,公司股东人数为9988户。感谢您对公司的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300023284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664009770","title":"股市必读:东亚药业新发布《东亚药业关于2026年半年度计提资产减值准备的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664009770","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664009770?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:47","pubTimestamp":1788202030,"startTime":"0","endTime":"0","summary":"公司公告汇总:2026年半年度计提资产减值准备合计6,771.31万元,减少合并报表利润总额6,771.31万元。东亚药业2026年半年度报告摘要截至2026年6月30日,公司总资产为3,068,107,266.70元,较上年度末减少8.08%;归属于上市公司股东的净资产为1,703,469,373.15元,较上年度末减少5.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663807245","title":"东亚药业(605177)披露2026年半年度报告,8月31日股价上涨1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663807245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663807245?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:54","pubTimestamp":1788173656,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,东亚药业报收于21.67元,较前一交易日上涨1.03%,最新总市值为24.86亿元。该股当日开盘21.09元,最高21.67元,最低20.78元,成交额达8414.3万元,换手率为3.48%。近日,东亚药业披露《2026年半年度报告》。公告显示,截至报告期末,公司总资产为3,068,107,266.70元,较上年度末减少8.08%;归属于上市公司股东的净资产为1,703,469,373.15元,较上年度末减少5.67%。公司2026年上半年不进行利润分配,也不进行公积金转增股本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663490240","title":"图解东亚药业中报:第二季度单季净利润同比下降256.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663490240","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663490240?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:40","pubTimestamp":1788082854,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业2026年中报显示,上半年度公司主营收入4.66亿元,同比上升12.09%;归母净利润-1.18亿元,同比下降291.61%;扣非净利润-1.24亿元,同比下降244.29%;其中2026年第二季度,公司单季度主营收入2.02亿元,同比下降10.39%;单季度归母净利润-8317.53万元,同比下降256.84%;单季度扣非净利润-8489.74万元,同比下降234.57%;负债率44.48%,投资收益216.7万元,财务费用1798.91万元,毛利率23.88%。财报数据概要请见下图:本文数据来源于东亚药业2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000012897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791841834363,"stockEarnings":[{"period":"1week","weight":0.0495},{"period":"1month","weight":0.0802},{"period":"3month","weight":0.544},{"period":"6month","weight":0.2673},{"period":"1year","weight":0.3233},{"period":"ytd","weight":0.4303}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江东亚药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11696人(较上一季度增加17.10%)","perCapita":"9717股","listingDate":"2020-11-25","address":"浙江省台州市三门县浦坝港镇沿海工业城","registeredCapital":"11470万元","survey":" 浙江东亚药业股份有限公司的主营业务是化学原料药、医药中间体、化学制剂的研发、生产和销售业务。公司的主要产品是抗细菌类药物(β-内酰胺类和喹诺酮类)、消化系统药物、皮肤用抗真菌药物等。公司在浙江三门、浙江临海、江西九江建有一体化的制药基地,并在上海张江药谷、杭州下沙医药港小镇设有现代化的研发中心,先后获得“国家高新技术企业”“浙江省专利示范企业”“台州市管理创新十强企业”等称号。","listedPrice":31.13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东亚药业,605177,东亚药业股票,东亚药业股票老虎,东亚药业股票老虎国际,东亚药业行情,东亚药业股票行情,东亚药业股价,东亚药业股市,东亚药业股票价格,东亚药业股票交易,东亚药业股票购买,东亚药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}